They used radiolabelled cyclic NGR derivatives with the 68Ga radiometal in order to assess their APN/CD13 selectivity in vivo through PET/CT imaging in syngeneic hepatocellular carcinoma (He/De) and mesoblastic nephroma (Ne/De) tumour models. This evidence concerns the gene ANPEP and hepatocellular carcinoma.